132 related articles for article (PubMed ID: 11033411)
1. The level of typical biomarker of oxidative stress 8-hydroxy-2'-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor.
Foksinski M; Kotzbach R; Szymanski W; Olinski R
Free Radic Biol Med; 2000 Oct; 29(7):597-601. PubMed ID: 11033411
[TBL] [Abstract][Full Text] [Related]
2. Relationship of myoma cell size and menopausal status in small uterine leiomyomas.
Cramer SF; Marchetti C; Freedman J; Padela A
Arch Pathol Lab Med; 2000 Oct; 124(10):1448-53. PubMed ID: 11035573
[TBL] [Abstract][Full Text] [Related]
3. The expression of aquaporin 1 and 5 in uterine leiomyomata in premenopausal women: a preliminary study.
Skowronski MT; Frackowiak L; Skowronska A
Reprod Biol; 2012 Mar; 12(1):81-9. PubMed ID: 22472942
[TBL] [Abstract][Full Text] [Related]
4. Transvaginal Doppler examination of uteri with myomas.
Sladkevicius P; Valentin L; Marsál K
J Clin Ultrasound; 1996; 24(3):135-40. PubMed ID: 8838302
[TBL] [Abstract][Full Text] [Related]
5. Estimation of tissue and crevicular fluid oxidative stress marker in premenopausal, perimenopausal and postmenopausal women with chronic periodontitis.
Chandra RV; Sailaja S; Reddy AA
Gerodontology; 2017 Sep; 34(3):382-389. PubMed ID: 28568604
[TBL] [Abstract][Full Text] [Related]
6. [Uterine leiomyoma: pathology and epidemiology].
Cabrera J; Mucientes F; Klaassen R; Acosta S; Oliva JP
Rev Chil Obstet Ginecol; 1994; 59(1):39-43. PubMed ID: 7809431
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
Higashijima T; Kataoka A; Nishida T; Yakushiji M
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
[TBL] [Abstract][Full Text] [Related]
8. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis.
Kasai H
Mutat Res; 1997 Dec; 387(3):147-63. PubMed ID: 9439711
[TBL] [Abstract][Full Text] [Related]
9. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy.
Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Masuzaki H
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():6-13. PubMed ID: 25697974
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis.
Huang SC; Yu CH; Huang RT; Hsu KF; Tsai YC; Chou CY
Obstet Gynecol; 1996 Jun; 87(6):1019-24. PubMed ID: 8649683
[TBL] [Abstract][Full Text] [Related]
12. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB).
Lasmar RB; Lasmar BP
Best Pract Res Clin Obstet Gynaecol; 2017 Apr; 40():82-88. PubMed ID: 27784616
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal, and gonadotropin-releasing hormone agonist-treated females.
Brosens I; Johannisson E; Dal Cin P; Deprest J; Van den Berghe H
Fertil Steril; 1996 Sep; 66(3):376-9. PubMed ID: 8751732
[TBL] [Abstract][Full Text] [Related]
14. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
15. Significance of postmenopausal uterine leiomyomas: Focus on variants.
Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
[TBL] [Abstract][Full Text] [Related]
16. Tissue levels of cadmium and trace elements in patients with myoma and uterine cancer.
Nasiadek M; Krawczyk T; Sapota A
Hum Exp Toxicol; 2005 Dec; 24(12):623-30. PubMed ID: 16408615
[TBL] [Abstract][Full Text] [Related]
17. Benign and malignant changes in uterine myomas.
NOVAK ER
Clin Obstet Gynecol; 1958 Jun; 1(2):421-8. PubMed ID: 13573686
[No Abstract] [Full Text] [Related]
18. Lipid-rich residual bodies and cathepsin D in the human uterus: ultrastructural and quantitative comparison between normal myometrium and leiomyoma.
Yamazaki K; Yakumaru K; Eyden BP
J Submicrosc Cytol Pathol; 1993 Jul; 25(3):437-47. PubMed ID: 8402543
[TBL] [Abstract][Full Text] [Related]
19. [Cadmium concentration in uterine myomas, myometrium and peripheral blood from women living in Lower Silesia].
Pochwałowski M
Ginekol Pol; 2001 Dec; 72(12):1055-8. PubMed ID: 11883208
[TBL] [Abstract][Full Text] [Related]
20. [Oxidative metabolism of uterine smooth muscular tissue in norm and neoplastic growth (clinical and experimental studies)].
Paĭlodze MV; Sanikidze TV
Morfologiia; 2005; 127(3):55-8. PubMed ID: 16381315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
